Cellceutix Corp (OTCMKTS:CTIX) Fallings Amidst Positive PR

[[tagnumber 0]][[tagnumber 1]]After a long period of sliding down the charts we saw Cellceutix Corp (OTCMKTS:CTIX) try to regain some of the lost value in the end of last month. This turned out to be quite difficult and after a bit of sliding in the beginning of November we saw [[tagnumber 2]]CTIX[[tagnumber 3]] spike once again.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]Unfortunately, the spike in price was short–lived and the ticker came back sliding after that. Meanwhile, we got to see the company’s results for the third quarter of the year. The report for the period ended September 30 contained the following numbers of prime interest.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 11]] [[tagnumber 12]]cash: $7.77 million[[tagnumber 13]] [[tagnumber 12]]current assets: $8 million[[tagnumber 13]] [[tagnumber 12]]current liabilities: $7.5 million[[tagnumber 13]] [[tagnumber 12]]revenues: ZERO[[tagnumber 13]] [[tagnumber 12]]net loss: $2.57 million[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]Now, we know that [[tagnumber 2]]CTIX[[tagnumber 3]] has been doing pretty well for an OTC marketplace company, although it is still unable to generate revenues. That is because its products are still undergoing clinical trials, but we see that [[tagnumber 2]]CTIX[[tagnumber 3]] is having progress with several of its treatments.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]Still, it does have a market cap of more than $150 million so it is not such a big surprise that we often see it close in the red. The latest session saw the ticker finish with a 10.07% loss and close at $1.34 while a total of 189 thousand traded shares generated $$273 thousand in daily dollar volume.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]This is all happening while [[tagnumber 2]]CTIX[[tagnumber 3]] is issuing press releases, but we see that the ticker shows a bit more optimism today. The company stock is sitting 5.97% in the green as of the writing of this article and we might see it regain some of the value it had lost in the previous session.[[tagnumber 4]]